Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 915 | 1232 | 810 | 478 | 637 | 692 |
Fund Return | -8.46% | 23.15% | -19.03% | -21.82% | -8.63% | -3.62% |
Place in category | 32 | 5 | 28 | 13 | 9 | 6 |
% in Category | 90 | 11 | 93 | 90 | 100 | 100 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
001668 | 20.35B | 6.43 | 2.27 | - | ||
China Universal Consumer Industries | 13.91B | 6.83 | -14.16 | 17.24 | ||
China Universal Selective Mixed Sec | 9.46B | 9.73 | -14.13 | 12.29 | ||
China Universal Blue Chip Equity Fu | 4.62B | 1.80 | -15.39 | 12.79 | ||
China Universal CSI 300 Dynamic Str | 4.21B | 7.52 | -1.09 | 10.07 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
E Fund Mid Small Cap | 14.39B | 3.28 | -15.16 | 15.57 | ||
Fullgoal China Small Cap Stock Fund | 2.74B | 9.19 | -8.62 | 6.58 | ||
FTS Great China Selec Bal Fd QDII | 1.72B | 6.72 | -11.92 | - | ||
Harvest Overseas China QDII | 1.53B | 7.06 | -16.25 | 0.78 | ||
IGW Greater China Equity Fund[QDII] | 994.82M | -1.34 | -12.04 | 5.55 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sichuan Kelun Biotech | CNE1000062J1 | 11.96 | 170.70 | -1.22% | |
Hansoh Pharmaceutical Group | KYG549581067 | 10.15 | 18.24 | +1.33% | |
Keymed Biosciences Inc | - | 8.51 | - | - | |
Genscript Biotech Corp | KYG3825B1059 | 7.38 | 12.38 | -0.64% | |
Remegen | CNE1000048G6 | 6.07 | 31.00 | -5.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Neutral |
Technical Indicators | Strong Buy | Strong Buy | Sell |
Summary | Strong Buy | Strong Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review